Recombinant multi-species Cytokeratin 18/KRT18 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cytokeratin 18/KRT18 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
KRT18 encodes the type I intermediate filament chain keratin 18. Keratin 18, together with its filament partner keratin 8, are perhaps the most commonly found members of the intermediate filament gene family. They are expressed in single layer epithelial tissues of the body. Mutations in this gene have been linked to cryptogenic cirrhosis. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CK-18,CK18,CYK18,Cell proliferation-inducing gene 46 protein,Cytokeratin 18,Cytokeratin-18 (CK-18),K18,KRT18,Keratin,Keratin-18 (K18),Krt1-18,Krt18,type I cytoskeletal 18

Target products collectionGo to Cytokeratin 18/KRT18 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8462-Ag-1/ GM-Tg-hg-IP8462-Ag-2 Human Cytokeratin 18/KRT18 protein Human
GM-Tg-rg-IP8462-Ag-1/ GM-Tg-rg-IP8462-Ag-2 Rat Cytokeratin 18/KRT18 protein Rat
GM-Tg-mg-IP8462-Ag-1/ GM-Tg-mg-IP8462-Ag-2 Mouse Cytokeratin 18/KRT18 protein Mouse
GM-Tg-cynog-IP8462-Ag-1/ GM-Tg-cynog-IP8462-Ag-2 Cynomolgus/Rhesus macaque Cytokeratin 18/KRT18 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8462-Ag-1/ GM-Tg-felg-IP8462-Ag-2 Feline Cytokeratin 18/KRT18 protein Feline
GM-Tg-cang-IP8462-Ag-1/ GM-Tg-cang-IP8462-Ag-2 Canine Cytokeratin 18/KRT18 protein Canine
GM-Tg-bovg-IP8462-Ag-1/ GM-Tg-bovg-IP8462-Ag-2 Bovine Cytokeratin 18/KRT18 protein Bovine
GM-Tg-equg-IP8462-Ag-1/ GM-Tg-equg-IP8462-Ag-2 Equine Cytokeratin 18/KRT18 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8462-Ag-1/ GM-Tg-hg-IP8462-Ag-2; GM-Tg-rg-IP8462-Ag-1/ GM-Tg-rg-IP8462-Ag-2;
GM-Tg-mg-IP8462-Ag-1/ GM-Tg-mg-IP8462-Ag-2; GM-Tg-cynog-IP8462-Ag-1/ GM-Tg-cynog-IP8462-Ag-2;
GM-Tg-felg-IP8462-Ag-1/ GM-Tg-felg-IP8462-Ag-2; GM-Tg-cang-IP8462-Ag-1/ GM-Tg-cang-IP8462-Ag-2;
GM-Tg-bovg-IP8462-Ag-1/ GM-Tg-bovg-IP8462-Ag-2; GM-Tg-equg-IP8462-Ag-1/ GM-Tg-equg-IP8462-Ag-2
Products Name Cytokeratin 18/KRT18 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Cytokeratin 18/KRT18
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cytokeratin 18/KRT18 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.